Table 2. Risk factors identified in all participants at baseline.
| Risk Factor | No. Participants (n = 268) |
% |
|---|---|---|
| ≥1 Fall risk increasing drug | 204 | 76 |
| Fear of falling (Short FES-I>11) | 177 | 66 |
| Gait and balance abnormalities | 158 | 60 |
| Orthostatic hypotension | 103 | 59 |
| Visual disorder | 134 | 50 |
| Depression (DASS-21 Depression>7) | 102 | 38 |
| Suspected home hazards* | 82 | 31 |
| Anxiety (DASS-21 Anxiety>6) | 75 | 28 |
| Arthritis | 69 | 26 |
| Visual impairment | 65 | 25 |
| Vasovagal syncope* | 61 | 23 |
| Poor footwear | 52 | 17 |
| Osteoarthritis | 48 | 18 |
| Stress (DASS-21 Stress>10) | 27 | 10 |
| Foot problems | 27 | 10 |
| Hearing impairment | 30 | 11 |
| Situational syncope | 22 | 8 |
| Peripheral neuropathy | 18 | 7 |
| Incontinence | 10 | 4 |
| Spinal problems | 10 | 4 |
| Stroke disease | 8 | 3 |
| Parkinson’s disease | 6 | 2 |
* Clinically diagnosed ± Tilt-table test. FES-I = Falls Efficacy Scale-International, DASS-21 = 21-item Depression, Anxiety and Stress Scale.
Note: Based on clinical assessment and participant self-report at baseline assessment.